Skip to main content
xMedica

Search

164 studies match these filters. Showing 101–125 of 164 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT07654374A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in participants living with overweight or obesity and T2DM. Participants will be randomized to aleniglipron or placebo for a total of 76 weeks of treatment.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 74 sites in total · contact listed

RecruitingPhase 31,100target74 / 12026Sep 11, 2026
NCT07069673Abbott Cephea Mitral Valve Disease Registry

The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of cor…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 24 sites in total · contact listed

Recruiting1,000target24 / 12025Sep 10, 2026
NCT03959085Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab ozogamicin is a monoclonal antibody, which is a type of protei…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 231 sites in total · contact listed

RecruitingPhase 35,951target231 / 52019Aug 25, 2026
NCT04566328Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell g…

Contact Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 647 sites in total

RecruitingPhase 31,450target647 / 22021Aug 19, 2026
NCT07654361Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses of aleniglipron once daily (QD) compared with placebo, when used in combination with a reduced-calor…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 71 sites in total · contact listed

RecruitingPhase 33,600target71 / 12026Aug 10, 2026
NCT05172973ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with a failing aortic bioprosthetic valve.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 36 sites in total

RecruitingNot applicable200target36 / 22023Jul 27, 2026
NCT06533644A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

The primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerated dose (MTD) and/or selected dose for phase 2b study.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total

RecruitingPhase 291target23 / 12025Jun 23, 2026
NCT07190300TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

The purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total · contact listed

RecruitingPhase 1 / Phase 2181target31 / 142026Jun 23, 2026
NCT07207408Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

This study will evaluate the immunogenicity, safety, and tolerability of rF1V-1018 vaccine

Contact Claimed

Nearest site: El Dorado, Kansas, United States — 85 km away · 4 sites in total

RecruitingPhase 2148target4 / 12025Jun 18, 2026
NCT05491525Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 38 sites in total · contact listed

RecruitingPhase 2 / Phase 371target38 / 162022Jun 15, 2026
NCT06628908Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 76 sites in total

RecruitingPhase 31,100target76 / 12024Jun 15, 2026
NCT06527222A Study of Ranolazine in ALS

The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 6 sites in total · contact listed

RecruitingPhase 272target6 / 12025Jun 8, 2026
NCT07382167A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess the safety and efficacy of tenapanor (5 mg, 25mg, and 50 mg) in adult patients with Chronic Idiopathic Constipation (CIC) when administered twice daily f…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 109 sites in total · contact listed

RecruitingPhase 3692target109 / 12026Jun 4, 2026
NCT05675410A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in improving survival in patients with stage I and II classical Hodgkin lymphoma. Brentuximab vedotin is…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 415 sites in total · contact listed

RecruitingPhase 31,875target415 / 32023Sep 18, 2026
NCT07609108Pridopidine Phase 3 Study in Huntington's Disease

The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall worsening of HD over…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 66 sites in total · contact listed

RecruitingPhase 3400target66 / 122026Sep 17, 2026
NCT04181060Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signa…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 603 sites in total · contact listed

RecruitingPhase 3300target603 / 12020Sep 10, 2026
NCT07662213A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering medication(s).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 209 sites in total

RecruitingPhase 31,200target209 / 152026Sep 9, 2026
NCT06510374Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 107 sites in total

RecruitingPhase 3454target107 / 92024Sep 4, 2026
NCT05913908EFS of the DUO System for Tricuspid Regurgitation

The study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcatheter Tricuspid Coaptation Valve System (DUO System).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 15 sites in total · contact listed

RecruitingNot applicable15target15 / 22024Jun 1, 2026
NCT06693895A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age

The purpose of this study is to assess how well-tolerated GSK's investigational varicella vaccine (VNS Vaccine) is, in comparison to an already approved varicella vaccine (VV) known as Varivax. The study will be conducted on healthy children aged 12 to 15 months, and who have neither contracted vari…

Contact Claimed

Nearest site: El Dorado, Kansas, United States — 85 km away · 46 sites in total

RecruitingPhase 3750target46 / 82024May 29, 2026
NCT06777368REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 71 sites in total · contact listed

Recruiting225target71 / 12025May 28, 2026
NCT03851445Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will deter…

Contact Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 1,229 sites in total

RecruitingPhase 2 / Phase 310,000target1,229 / 12019May 18, 2026
NCT06172296Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 179 sites in total · contact listed

RecruitingPhase 3478target179 / 52024Sep 17, 2026
NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 629 sites in total · contact listed

RecruitingPhase 31,780target629 / 92017Aug 25, 2026
NCT06535854Prevail Global Study

The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 51 sites in total · contact listed

RecruitingNot applicable1,205target51 / 12025Apr 24, 2026

Filters

Clear all filters